Literature DB >> 4371298

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients.

H Gavras, H R Brunner, J H Laragh, J E Sealey, I Gavras, R A Vukovich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4371298     DOI： 10.1056/NEJM197410172911603

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  38 in total

1.  Editorial: New prospects in renal hypertension.

Authors: 
Journal:  Br Med J       Date:  1975-07-12

Review 2.  The renin-angiotensin-aldosterone system in 2011: role in hypertension and chronic kidney disease.

Authors:  Ana Cristina Simões E Silva; Joseph T Flynn
Journal:  Pediatr Nephrol       Date:  2011-09-23       Impact factor: 3.714

3.  First International Symposium on Cilazapril Preclinical and Clinical Pharmacology. Lausanne, switzerland, May 5-7, 1988. Proceedings.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1989       Impact factor: 4.335

4.  Hypotension during angiotensin blockade with saralasin.

Authors:  R Beckerhoff; J Furrer; W Vetter; J Nussberger; W Siegenthaler
Journal:  Br Med J       Date:  1976-10-09

5.  A simple radioassay for angiotensin-converting enzyme.

Authors:  J W Ryan; A Chung; C Ammons; M L Carlton
Journal:  Biochem J       Date:  1977-11-01       Impact factor: 3.857

Review 6.  Antihypertensive drugs: clinical pharmacology and therapeutic use.

Authors:  G L Wollam; R W Gifford; R C Tarazi
Journal:  Drugs       Date:  1977-12       Impact factor: 9.546

7.  Human placental leucine aminopeptidase (P-LAP) as a hypotensive agent.

Authors:  S Mizutani; K Okano; E Hasegawa; H Sakura; M Oya; M Yamada
Journal:  Experientia       Date:  1982-07-15

8.  Effects of captopril on pulmonary haemodynamics.

Authors:  C Richard; J L Ricome; A Rimailho; M Conrad; P Auzépy
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

9.  Functional genetic variation in aminopeptidase A (ENPEP): lack of clear association with focal and segmental glomerulosclerosis (FSGS).

Authors:  Stephen Tonna; Savita V Dandapani; Andrea Uscinski; Gerald B Appel; Johannes S Schlöndorff; Kang Zhang; Bradley M Denker; Martin R Pollak
Journal:  Gene       Date:  2007-12-03       Impact factor: 3.688

10.  Fate of bradykinin-potentiating peptide 9a after intravenous injection.

Authors:  L C Martin; J W Ryan; G H Fisher; A Chung; M Epstein; J M Stewart
Journal:  Biochem J       Date:  1979-12-15       Impact factor: 3.857
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.